Open Label, Single Arm Technology-Assisted Cholesterol Trial for High Cholesterol (TACTiC Trial)

"The aim of this clinical trial, which will be gauged over a period of 6 months, is to study the percentage of participants that have a positive final use outcome. Additionally, the secondary outcomes of this trial include the percentage of participants who correctly identify a "Stop Use" warning and comply with the medication regimen, the percentage of participants that are considered compliant with continuous dosing, and finally, the percentage of participants who correctly identify a "Do Not Use" warning."

"45 different clinical trials are currently underway to research this treatment. Of those, 13 are in Phase 3. The 331 locations conducting these trials are primarily based in Miami, Florida."

"This trial is seeking 1189 individuals aged 20-75 who have cholesterol. Patients must also meet the following criteria: 1. Must have signed the Informed Consent form, Males, 20-75 years of age, Females, 20-75 years of age (Inclusion criteria for females will be revised to only enrolling women aged 50-75 once 50 women under 50 have been enrolled in the study), Responding to advertising about high cholesterol or heart health concerns, Must be able to read, speak, and understand English, Additional Criteria for Inclusion for Actual Use (at Virtual Visit 1)."

"This study isn't recruiting patients at the moment, however that could change in the future. The trial was first posted on July 8th, 2021 and was last updated on September 29th, 2022. If you're interested in similar studies, there are 72 clinical trials actively recruiting patients with cholesterol and 45 trials for this treatment actively recruiting participants."

"This trial's age range begins at 20 years old and concludes at 75 years old."

"This is a Phase 3 trial, which means that while there is some data supporting efficacy, multiple rounds of data supporting safety exist--so our team at Power rates the safety of this treatment as a 3."

"Medications in this class are typically used to treat hypertriglyceridemia. They may also be effective for preventing cardiovascular disease, cardiovascular events, and complications from cardiovascular surgeries."

"As of now, this study is not recruiting patients for participation. The trial was originally posted on July 8th, 2021 and was most recently updated on September 29th, 2022. If you are looking for other trials, there are 72 cholesterol studies and 45 trials for this specific treatment that are actively recruiting patients."